Literature DB >> 23821189

Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.

Kathryn G Ewens1, Peter A Kanetsky, Jennifer Richards-Yutz, Saad Al-Dahmash, Maria Carla De Luca, Carlos G Bianciotto, Carol L Shields, Arupa Ganguly.   

Abstract

PURPOSE: Uveal melanoma (UM) was a fatal malignancy in 40% to 50% of cases. The aim of this study is to evaluate the independent contributions of chromosome 1, 3, 6, and 8 abnormalities for prognostication of metastasis, and to define multichromosome copy number aberration (CNA) signatures that can be used to evaluate risk.
METHODS: A series of 320 UM were analyzed for chromosome 1, 3, 6, and 8 abnormalities using whole genome single-nucleotide polymorphism arrays. Results for changes in six chromosomal regions were analyzed using univariate and multivariate Cox proportional hazard modeling to identify significant predictors of metastasis and CNA signatures.
RESULTS: Univariate Cox analysis indicated that losses of chromosome 3, 1p, 6q, and 8p and gain of 8q, as well as sex, source of tumor tissue (fine-needle aspiration biopsy [FNAB] compared with tumor from an enucleated eye), tumor basal diameter and height, and ciliary body involvement were all significant predictors of poor metastatic outcome. In the multivariate analysis, loss of chromosome 3 and 8p remained significant after adjusting for the effects of all other variables, as did sex, tissue source, and basal diameter. Multivariate analysis of the joint effects of changes in the six chromosomal regions showed that six signatures, including chromosome 3-loss, 1p-loss, 8p-loss, and/or 8q-gain had hazard ratios (HR) ranging from 7.90 to 37.25.
CONCLUSIONS: In UM, tumor size and location, tissue source, and sex were all significantly associated with increased metastasis. In addition, chromosome 3-loss and 8p-loss were found to be independent predictors of poor metastatic outcome and CNA signatures were identified that can add a specific HR value for classification of risk categories.

Entities:  

Keywords:  SNP arrays; chromosome changes; marker; prognosis; uveal melanoma

Mesh:

Substances:

Year:  2013        PMID: 23821189     DOI: 10.1167/iovs.13-12195

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

2.  Prognostic parameters in uveal melanoma and their association with BAP1 expression.

Authors:  T Huibertus van Essen; Sake I van Pelt; Mieke Versluis; Inge H G Bronkhorst; Sjoerd G van Duinen; Marina Marinkovic; Wilma G M Kroes; Claudia A L Ruivenkamp; Shruti Shukla; Annelies de Klein; Emine Kiliç; J William Harbour; Gregorius P M Luyten; Pieter A van der Velden; Rob M Verdijk; Martine J Jager
Journal:  Br J Ophthalmol       Date:  2014-08-21       Impact factor: 4.638

3.  Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.

Authors:  Kyra N Smit; Natasha M van Poppelen; Jolanda Vaarwater; Robert Verdijk; Ronald van Marion; Helen Kalirai; Sarah E Coupland; Sophie Thornton; Neil Farquhar; Hendrikus-Jan Dubbink; Dion Paridaens; Annelies de Klein; Emine Kiliç
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 4.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

Review 5.  Choroidal biopsies; a review and optimised approach.

Authors:  R N Hussain; B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2022-08-08       Impact factor: 4.456

6.  Linking tissues to phenotypes using gene expression profiles.

Authors:  Anika Oellrich; Damian Smedley
Journal:  Database (Oxford)       Date:  2014-03-13       Impact factor: 3.451

7.  Development and external validation of a prognostic nomogram for metastatic uveal melanoma.

Authors:  Sara Valpione; Justin C Moser; Raffaele Parrozzani; Marco Bazzi; Aaron S Mansfield; Simone Mocellin; Jacopo Pigozzo; Edoardo Midena; Svetomir N Markovic; Camillo Aliberti; Luca G Campana; Vanna Chiarion-Sileni
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 8.  The biology of uveal melanoma.

Authors:  Adriana Amaro; Rosaria Gangemi; Francesca Piaggio; Giovanna Angelini; Gaia Barisione; Silvano Ferrini; Ulrich Pfeffer
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

9.  Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.

Authors:  Vasilios P Papastefanou; Shahriar Islam; Teresa Szyszko; Marianne Grantham; Mandeep S Sagoo; Victoria M L Cohen
Journal:  Br J Ophthalmol       Date:  2014-08-01       Impact factor: 4.638

10.  Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.

Authors:  Mieke Versluis; Mark J de Lange; Sake I van Pelt; Claudia A L Ruivenkamp; Wilma G M Kroes; Jinfeng Cao; Martine J Jager; Gre P M Luyten; Pieter A van der Velden
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.